Click here to get full coverage on Why (IMCR) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Why (IMCR) Price Action Is Critical for Tactical Trading  Stock Traders Daily

Why (IMCR) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Click here to get full coverage on A melanoma drug doubled 5-year survival in a hard-to-treat cancer - Stock Titan

A melanoma drug doubled 5-year survival in a hard-to-treat cancer  Stock Titan

A melanoma drug doubled 5-year survival in a hard-to-treat cancer - Stock Titan

Click here to get full coverage on IMCR Reiterated by HC Wainwright & Co. -- Price Target Maintained at $100 - GuruFocus

IMCR Reiterated by HC Wainwright & Co. -- Price Target Maintained at $100  GuruFocus

IMCR Reiterated by HC Wainwright & Co. -- Price Target Maintained at $100 - GuruFocus

Click here to get full coverage on Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86 - Moomoo

Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86  Moomoo

Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86 - Moomoo

Click here to get full coverage on Immunocore (IMCR): KIMMTRAK’s Durable Survival Benefit in Metastatic Uveal Melanoma Underpins Sustainable Growth and $100 Buy Rating - TipRanks

Immunocore (IMCR): KIMMTRAK’s Durable Survival Benefit in Metastatic Uveal Melanoma Underpins Sustainable Growth and $100 Buy Rating  TipRanks

Immunocore (IMCR): KIMMTRAK’s Durable Survival Benefit in Metastatic Uveal Melanoma Underpins Sustainable Growth and $100 Buy Rating - TipRanks

Click here to get full coverage on Immunocore (IMCR) upgraded to strong buy: Here's why - MSN

Immunocore (IMCR) upgraded to strong buy: Here's why  MSN

Immunocore (IMCR) upgraded to strong buy: Here's why - MSN

Click here to get full coverage on Why The Narrative Around Immunocore (IMCR) Is Shifting With New Analyst Targets And 2026 Hopes - Yahoo Finance

Why The Narrative Around Immunocore (IMCR) Is Shifting With New Analyst Targets And 2026 Hopes  Yahoo Finance

Why The Narrative Around Immunocore (IMCR) Is Shifting With New Analyst Targets And 2026 Hopes - Yahoo Finance

Click here to get full coverage on Purported Iran-backed group claims responsibility for attacks in Belgium and Greece - Long War Journal

Purported Iran-backed group claims responsibility for attacks in Belgium and Greece  Long War Journal

Purported Iran-backed group claims responsibility for attacks in Belgium and Greece - Long War Journal

Click here to get full coverage on Immunocore (IMCR) Stock: Why It Could Plunge (Touches Low) 2026-04-20 - Senior Analyst Forecasts - Cổng thông tin điện tử Tỉnh Sơn La

Immunocore (IMCR) Stock: Why It Could Plunge (Touches Low) 2026-04-20 - Senior Analyst Forecasts  Cổng thông tin điện tử Tỉnh Sơn La

Immunocore (IMCR) Stock: Why It Could Plunge (Touches Low) 2026-04-20 - Senior Analyst Forecasts - Cổng thông tin điện tử Tỉnh Sơn La

Click here to get full coverage on Immunocore executives join Needham virtual healthcare event April 13 - Stock Titan

Immunocore executives join Needham virtual healthcare event April 13  Stock Titan

Immunocore executives join Needham virtual healthcare event April 13 - Stock Titan

Click here to get full coverage on Immunocore Holdings (IMCR) is One of the Best Small Cap Stocks Ready to Explode in 2026 - Yahoo Finance

Immunocore Holdings (IMCR) is One of the Best Small Cap Stocks Ready to Explode in 2026  Yahoo Finance

Immunocore Holdings (IMCR) is One of the Best Small Cap Stocks Ready to Explode in 2026 - Yahoo Finance

Click here to get full coverage on [ARS] Immunocore Holdings plc SEC Filing - Stock Titan

[ARS] Immunocore Holdings plc SEC Filing  Stock Titan

[ARS] Immunocore Holdings plc SEC Filing - Stock Titan

Click here to get full coverage on Immunocore (IMCR) Soars 5.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Immunocore (IMCR) Soars 5.9%: Is Further Upside Left in the Stock?  Yahoo Finance

Immunocore (IMCR) Soars 5.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on Immunocore (NASDAQ: IMCR) outlines 10 resolutions for 2026 hybrid AGM - Stock Titan

Immunocore (NASDAQ: IMCR) outlines 10 resolutions for 2026 hybrid AGM  Stock Titan

Immunocore (NASDAQ: IMCR) outlines 10 resolutions for 2026 hybrid AGM - Stock Titan

Click here to get full coverage on A Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth Concerns - Yahoo Finance

A Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth Concerns  Yahoo Finance

A Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth Concerns - Yahoo Finance

Click here to get full coverage on How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets - Yahoo Finance

How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets  Yahoo Finance

How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets - Yahoo Finance

Click here to get full coverage on Understanding Momentum Shifts in (IMCR) - Stock Traders Daily

Understanding Momentum Shifts in (IMCR)  Stock Traders Daily

Understanding Momentum Shifts in (IMCR) - Stock Traders Daily

Click here to get full coverage on Immunocore Holdings Plc (NASDAQ: IMCR) plans same‑day cashless sale of 25,000 ADRs - Stock Titan

Immunocore Holdings Plc (NASDAQ: IMCR) plans same‑day cashless sale of 25,000 ADRs  Stock Titan

Immunocore Holdings Plc (NASDAQ: IMCR) plans same‑day cashless sale of 25,000 ADRs - Stock Titan

Click here to get full coverage on Jefferies Downgrades Immunocore Holdings plc (IMCR) to Hold with a $33 Price Target - Yahoo Finance

Jefferies Downgrades Immunocore Holdings plc (IMCR) to Hold with a $33 Price Target  Yahoo Finance

Jefferies Downgrades Immunocore Holdings plc (IMCR) to Hold with a $33 Price Target - Yahoo Finance

Click here to get full coverage on Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75 - Moomoo

Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75  Moomoo

Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75 - Moomoo

Click here to get full coverage on Immunocore Holdings PLC (IMCR) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Immunocore Holdings PLC (IMCR) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...  Yahoo Finance

Immunocore Holdings PLC (IMCR) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Two promotions, one exit: inside Immunocore’s R&D shake-up - Stock Titan

Two promotions, one exit: inside Immunocore’s R&D shake-up  Stock Titan

Two promotions, one exit: inside Immunocore’s R&D shake-up - Stock Titan

Click here to get full coverage on New cancer, HIV and diabetes trials on deck in 2026 from Immunocore - Stock Titan

New cancer, HIV and diabetes trials on deck in 2026 from Immunocore  Stock Titan

New cancer, HIV and diabetes trials on deck in 2026 from Immunocore - Stock Titan

Click here to get full coverage on Biotech firm Immunocore lines up March investor talks in Miami and more - Stock Titan

Biotech firm Immunocore lines up March investor talks in Miami and more  Stock Titan

Biotech firm Immunocore lines up March investor talks in Miami and more - Stock Titan

Click here to get full coverage on Assessing Immunocore Holdings (IMCR) Valuation After Analyst Downgrade And Pipeline Timing Shift - simplywall.st

Assessing Immunocore Holdings (IMCR) Valuation After Analyst Downgrade And Pipeline Timing Shift  simplywall.st

Assessing Immunocore Holdings (IMCR) Valuation After Analyst Downgrade And Pipeline Timing Shift - simplywall.st

Click here to get full coverage on Immunocore (IMCR): Clinical Momentum, Credible Management, and Industry Visibility Support Buy Rating - TipRanks

Immunocore (IMCR): Clinical Momentum, Credible Management, and Industry Visibility Support Buy Rating  TipRanks

Immunocore (IMCR): Clinical Momentum, Credible Management, and Industry Visibility Support Buy Rating - TipRanks

Click here to get full coverage on Cancer drug KIMMTRAK to reveal 5-year survival data at 2026 AACR meeting - Stock Titan

Cancer drug KIMMTRAK to reveal 5-year survival data at 2026 AACR meeting  Stock Titan

Cancer drug KIMMTRAK to reveal 5-year survival data at 2026 AACR meeting - Stock Titan

Click here to get full coverage on Will Strong Revenue Growth but Narrowed Profits Shift Immunocore Holdings' (IMCR) Investment Story? - Yahoo Finance

Will Strong Revenue Growth but Narrowed Profits Shift Immunocore Holdings' (IMCR) Investment Story?  Yahoo Finance

Will Strong Revenue Growth but Narrowed Profits Shift Immunocore Holdings' (IMCR) Investment Story? - Yahoo Finance

Click here to get full coverage on Immunocore: Continuing To Improve The Bottom Line, But Needing A Big Catalyst - Seeking Alpha

Immunocore: Continuing To Improve The Bottom Line, But Needing A Big Catalyst  Seeking Alpha

Immunocore: Continuing To Improve The Bottom Line, But Needing A Big Catalyst - Seeking Alpha

Click here to get full coverage on Avoiding Lag: Real-Time Signals in (IMCR) Movement - Stock Traders Daily

Avoiding Lag: Real-Time Signals in (IMCR) Movement  Stock Traders Daily

Avoiding Lag: Real-Time Signals in (IMCR) Movement - Stock Traders Daily

Click here to get full coverage on Immunocore sets Feb. 25 webcast for Q4 and full-year 2025 results - Stock Titan

Immunocore sets Feb. 25 webcast for Q4 and full-year 2025 results  Stock Titan

Immunocore sets Feb. 25 webcast for Q4 and full-year 2025 results - Stock Titan

Click here to get full coverage on Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative? - simplywall.st

Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative?  simplywall.st

Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative? - simplywall.st

Click here to get full coverage on IMCR SEC Filings - Immunocore Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan

IMCR SEC Filings - Immunocore Holdings Plc 10-K, 10-Q, 8-K Forms  Stock Titan

IMCR SEC Filings - Immunocore Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Is It Time To Reassess Immunocore (IMCR) After Recent Biotech Progress And Valuation Signals - simplywall.st

Is It Time To Reassess Immunocore (IMCR) After Recent Biotech Progress And Valuation Signals  simplywall.st

Is It Time To Reassess Immunocore (IMCR) After Recent Biotech Progress And Valuation Signals - simplywall.st

Click here to get full coverage on IMCR Should I Buy - Intellectia AI

IMCR Should I Buy - Intellectia AI

Click here to get full coverage on Blast at Jewish school fuels terror fears - MSN

Blast at Jewish school fuels terror fears  MSN

Blast at Jewish school fuels terror fears - MSN

Click here to get full coverage on Discipline and Rules-Based Execution in IMCR Response - Stock Traders Daily

Discipline and Rules-Based Execution in IMCR Response  Stock Traders Daily

Discipline and Rules-Based Execution in IMCR Response - Stock Traders Daily

Click here to get full coverage on Immunocore Reshapes R&D Leadership As Shares Trade Below Analyst Targets - simplywall.st

Immunocore Reshapes R&D Leadership As Shares Trade Below Analyst Targets  simplywall.st

Immunocore Reshapes R&D Leadership As Shares Trade Below Analyst Targets - simplywall.st

Click here to get full coverage on Immunocore to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Quiver Quantitative

Immunocore to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026  Quiver Quantitative

Immunocore to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Quiver Quantitative

Click here to get full coverage on Immunocore Holdings (NASDAQ:IMCR) Has Debt But No Earnings; Should You Worry? - simplywall.st

Immunocore Holdings (NASDAQ:IMCR) Has Debt But No Earnings; Should You Worry?  simplywall.st

Immunocore Holdings (NASDAQ:IMCR) Has Debt But No Earnings; Should You Worry? - simplywall.st

Click here to get full coverage on How does macroeconomics affect Immunocore (IMCR) Stock | Price at $31.44, Up 1.26% - Stock Analysis Community - Cổng thông tin điện tử tỉnh Lào Cai

How does macroeconomics affect Immunocore (IMCR) Stock | Price at $31.44, Up 1.26% - Stock Analysis Community  Cổng thông tin điện tử tỉnh Lào Cai

How does macroeconomics affect Immunocore (IMCR) Stock | Price at $31.44, Up 1.26% - Stock Analysis Community - Cổng thông tin điện tử tỉnh Lào Cai

Click here to get full coverage on Immunocore (IMCR) Q4 2025 Earnings Call Transcript - The Globe and Mail

Immunocore (IMCR) Q4 2025 Earnings Call Transcript  The Globe and Mail

Immunocore (IMCR) Q4 2025 Earnings Call Transcript - The Globe and Mail

Click here to get full coverage on Decoding Immunocore Holdings PLC (IMCR): A Strategic SWOT Insigh - GuruFocus

Decoding Immunocore Holdings PLC (IMCR): A Strategic SWOT Insigh  GuruFocus

Decoding Immunocore Holdings PLC (IMCR): A Strategic SWOT Insigh - GuruFocus

Click here to get full coverage on Is Immunocore (IMCR) Stock a Safe Investment | Price at $31.35, Up 1.69% - Most Watched Stocks - Cổng thông tin điện tử tỉnh Tây Ninh

Is Immunocore (IMCR) Stock a Safe Investment | Price at $31.35, Up 1.69% - Most Watched Stocks  Cổng thông tin điện tử tỉnh Tây Ninh

Is Immunocore (IMCR) Stock a Safe Investment | Price at $31.35, Up 1.69% - Most Watched Stocks - Cổng thông tin điện tử tỉnh Tây Ninh

Click here to get full coverage on Immunocore Holdings plc (IMCR) Stock Analysis: Potential 108.89% Upside Highlights Promising Biotech Prospects - DirectorsTalk Interviews

Immunocore Holdings plc (IMCR) Stock Analysis: Potential 108.89% Upside Highlights Promising Biotech Prospects  DirectorsTalk Interviews

Immunocore Holdings plc (IMCR) Stock Analysis: Potential 108.89% Upside Highlights Promising Biotech Prospects - DirectorsTalk Interviews

Click here to get full coverage on Immunocore Holdings plc's (NASDAQ:IMCR) Price Is Right But Growth Is Lacking After Shares Rocket 27% - simplywall.st

Immunocore Holdings plc's (NASDAQ:IMCR) Price Is Right But Growth Is Lacking After Shares Rocket 27%  simplywall.st

Immunocore Holdings plc's (NASDAQ:IMCR) Price Is Right But Growth Is Lacking After Shares Rocket 27% - simplywall.st

Click here to get full coverage on Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling an 89% Potential Upside in Biotechnology - DirectorsTalk Interviews

Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling an 89% Potential Upside in Biotechnology  DirectorsTalk Interviews

Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling an 89% Potential Upside in Biotechnology - DirectorsTalk Interviews

Click here to get full coverage on Immunocore (NASDAQ:IMCR) Stock Moves Reflect Larger Nasdaq Futures Biotech Trends - Kalkine Media

Immunocore (NASDAQ:IMCR) Stock Moves Reflect Larger Nasdaq Futures Biotech Trends  Kalkine Media

Immunocore (NASDAQ:IMCR) Stock Moves Reflect Larger Nasdaq Futures Biotech Trends - Kalkine Media

Click here to get full coverage on Immunocore announces resignation of head of research and development - Investing.com

Immunocore announces resignation of head of research and development  Investing.com

Immunocore announces resignation of head of research and development - Investing.com

Click here to get full coverage on Is it a Good Idea to Invest in Immunocore Stock Right Now? - Yahoo Finance

Is it a Good Idea to Invest in Immunocore Stock Right Now?  Yahoo Finance

Is it a Good Idea to Invest in Immunocore Stock Right Now? - Yahoo Finance

Click here to get full coverage on Immunocore Holdings plc Reports Q4 and Full Year 2025 Financial Results - TradingView

Immunocore Holdings plc Reports Q4 and Full Year 2025 Financial Results  TradingView

Immunocore Holdings plc Reports Q4 and Full Year 2025 Financial Results - TradingView

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Immunocore Holdings (IMCR) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Immunocore Holdings (IMCR)  The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Immunocore Holdings (IMCR) - The Globe and Mail

Click here to get full coverage on Immunocore to present at upcoming investor conferences - Investing News Network

Immunocore to present at upcoming investor conferences  Investing News Network

Immunocore to present at upcoming investor conferences - Investing News Network

Click here to get full coverage on H.C. Wainwright reiterates Immunocore stock rating citing KIMMTRAK penetration By Investing.com - Investing.com South Africa

H.C. Wainwright reiterates Immunocore stock rating citing KIMMTRAK penetration By Investing.com  Investing.com South Africa

H.C. Wainwright reiterates Immunocore stock rating citing KIMMTRAK penetration By Investing.com - Investing.com South Africa

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Immunocore Holdings (IMCR) and Olema Pharmaceuticals (OLMA) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Immunocore Holdings (IMCR) and Olema Pharmaceuticals (OLMA)  The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Immunocore Holdings (IMCR) and Olema Pharmaceuticals (OLMA) - The Globe and Mail

Click here to get full coverage on Immunocore Holdings plc SEC 10-K Report - TradingView

Immunocore Holdings plc SEC 10-K Report  TradingView

Immunocore Holdings plc SEC 10-K Report - TradingView

Click here to get full coverage on Is Immunocore (IMCR) Stock a Safe Investment | Price at $31.35, Up 1.69% - Top Trending Breakouts - Xã Châu Thành

Is Immunocore (IMCR) Stock a Safe Investment | Price at $31.35, Up 1.69% - Top Trending Breakouts  Xã Châu Thành

Is Immunocore (IMCR) Stock a Safe Investment | Price at $31.35, Up 1.69% - Top Trending Breakouts - Xã Châu Thành

Click here to get full coverage on CSIR, IMCR to boost joint research, surveillance in health-related fields - The Tribune

CSIR, IMCR to boost joint research, surveillance in health-related fields  The Tribune

CSIR, IMCR to boost joint research, surveillance in health-related fields - The Tribune

Click here to get full coverage on Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates - Investing.com UK

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates  Investing.com UK

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates - Investing.com UK

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Jihad Being Deliberately Exploited: IMCR Chief Adeeb backs Madani’s Remarks - Clarion India

Jihad Being Deliberately Exploited: IMCR Chief Adeeb backs Madani’s Remarks  Clarion India

Jihad Being Deliberately Exploited: IMCR Chief Adeeb backs Madani’s Remarks - Clarion India

Click here to get full coverage on Immunocore Holdings: A Name On My Watch List (NASDAQ:IMCR) - Seeking Alpha

Immunocore Holdings: A Name On My Watch List (NASDAQ:IMCR)  Seeking Alpha

Immunocore Holdings: A Name On My Watch List (NASDAQ:IMCR) - Seeking Alpha

Click here to get full coverage on ‘Jihad’ Being Deliberately Exploited: IMCR Chief Mohammad Adeeb Backs Madani’s Remarks - Ommcom News

‘Jihad’ Being Deliberately Exploited: IMCR Chief Mohammad Adeeb Backs Madani’s Remarks  Ommcom News

‘Jihad’ Being Deliberately Exploited: IMCR Chief Mohammad Adeeb Backs Madani’s Remarks - Ommcom News

Click here to get full coverage on Immunocore (IMCR) - Zacks Investment Research

Immunocore (IMCR)  Zacks Investment Research

Immunocore (IMCR) - Zacks Investment Research

Click here to get full coverage on Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...  Yahoo Finance

Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Immunocore's KIMMTRAK Wins NHS Funding for Rare Melanoma Treatment - Stock Titan

Immunocore's KIMMTRAK Wins NHS Funding for Rare Melanoma Treatment  Stock Titan

Immunocore's KIMMTRAK Wins NHS Funding for Rare Melanoma Treatment - Stock Titan

Click here to get full coverage on Immunocore (NASDAQ:IMCR) Holdings: Market Position and Financial Insights within the Nasdaq 100 and S&P 500 - Kalkine Media

Immunocore (NASDAQ:IMCR) Holdings: Market Position and Financial Insights within the Nasdaq 100 and S&P 500  Kalkine Media

Immunocore (NASDAQ:IMCR) Holdings: Market Position and Financial Insights within the Nasdaq 100 and S&P 500 - Kalkine Media

Click here to get full coverage on What is the current Price Target and Forecast for Immunocore (IMCR) - Zacks Investment Research

What is the current Price Target and Forecast for Immunocore (IMCR)  Zacks Investment Research

IMCR

Price Chart

Key Statistics

Technicals

About IMCR

Latest News

Why (IMCR) Price Action Is Critical for Tactical Trading - Stock Traders Daily

A melanoma drug doubled 5-year survival in a hard-to-treat cancer - Stock Titan

IMCR Reiterated by HC Wainwright & Co. -- Price Target Maintained at $100 - GuruFocus

Advanced Charts

Top Gainers

Top Losers